Published in Neurology on April 13, 2004
Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology (2014) 3.36
Long-Term Antiplatelet Mono- and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta-Analysis. J Am Heart Assoc (2015) 0.81
Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis. BMJ Open (2016) 0.80
Access of HTB, main metabolite of triflusal, to cerebrospinal fluid in healthy volunteers. Eur J Clin Pharmacol (2005) 0.79
Prevention and Management of Cerebral Small Vessel Disease. J Stroke (2015) 0.79
Aspirin: it's hard to beat. Neurology (2004) 0.75
Gastrointestinal safety of triflusal solution in healthy volunteers: a proof of concept endoscopic study. Eur J Clin Pharmacol (2011) 0.75
Secretion of plasminogen activator by stimulated macrophages. J Exp Med (1974) 8.82
An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses. J Exp Med (1973) 5.53
Actinomycin and nucleic acid function. Prog Nucleic Acid Res Mol Biol (1964) 5.00
An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. II. Mammalian fibroblast cultures transformed by DNA and RNA tumor viruses. J Exp Med (1973) 4.99
A study of proteases and protease-inhibitor complexes in biological fluids. J Exp Med (1978) 3.92
Base specificity in the interaction of polynucleotides with antibiotic drugs. Science (1965) 3.72
Fluorescence studies of nucleotides and polynucleotides. I. Formycin, 2-aminopurine riboside, 2,6-diaminopurine riboside, and their derivatives. J Biol Chem (1969) 3.39
The human tissue plasminogen activator gene. J Biol Chem (1986) 3.35
Fibrinolysis associated with oncogenic transformation. Requirement of plasminogen for correlated changes in cellular morphology, colony formation in agar, and cell migration. J Exp Med (1973) 3.16
Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides. Cell (1976) 3.13
Fibrinolysis associated with oncogenic transformation. Partial purification and characterization of the cell factor, a plasminogen activator. J Biol Chem (1974) 2.89
Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm. Cell (1976) 2.87
Antibodies to plasminogen activator inhibit human tumor metastasis. Cell (1983) 2.82
Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol (2001) 2.73
Replication and inheritance of mitochondrial DNA. Proc Natl Acad Sci U S A (1966) 2.72
Activation of the oncogenic potential of the avian cellular src protein by specific structural alteration of the carboxy terminus. EMBO J (1987) 2.67
Secretion of plasminogen activator by human polymorphonuclear leukocytes. Modulation by glucocorticoids and other effectors. J Exp Med (1977) 2.60
Macrophage plasminogen activator: induction by concanavalin A and phorbol myristate acetate. Cell (1977) 2.47
[Estimation of the sample size in clinical and epidemiological investigations]. Med Clin (Barc) (1998) 2.18
Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator. Eur J Biochem (1985) 2.14
Mammary plasminogen activator: correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue. Cell (1979) 2.13
Typing and characterization of mechanisms of resistance of Shigella spp. isolated from feces of children under 5 years of age from Ifakara, Tanzania. J Clin Microbiol (1999) 2.11
High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators. J Epidemiol Community Health (1998) 2.08
Macrophage plasminogen activator: induction by products of activated lymphoid cells. J Exp Med (1977) 2.00
A proenzyme form of human urokinase. J Biol Chem (1982) 1.98
[Cefixime versus amoxicillin plus netilmicin in the treatment of community-acquired non-complicated acute pyelonephritis]. Med Clin (Barc) (1998) 1.95
Ovarian plasminogen activator: relationship to ovulation and hormonal regulation. Cell (1975) 1.93
Nucleotide sequence of a 13.9 kb segment of the 90 kb virulence plasmid of Salmonella typhimurium: the presence of fimbrial biosynthetic genes. Mol Microbiol (1993) 1.89
Properties of plasminogen activators formed by neoplastic human cell cultures. J Exp Med (1974) 1.88
Isolation and characterization of Clostridium botulinum type B toxin. J Biol Chem (1969) 1.79
Hormonal regulation of plasminogen activator mRNA production in porcine kidney cells. Cell (1983) 1.76
An integer-based score to predict functional outcome in acute ischemic stroke: the ASTRAL score. Neurology (2012) 1.75
The acetylcholine receptor. I. Purification and characterization of a macromolecule isolated from Electrophorus electricus. J Biol Chem (1973) 1.75
Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev (1996) 1.75
Structure and activity of acetylcholine. Nature (1970) 1.75
Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect (2008) 1.73
Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk. Eur J Vasc Endovasc Surg (2009) 1.72
Diarrhea in children under 5 years of age from Ifakara, Tanzania: a case-control study. J Clin Microbiol (2000) 1.72
Digestive anisakiasis: clinical manifestations and diagnosis according to localization. Rev Esp Enferm Dig (2002) 1.70
The interaction of actinomycin with DNA: requirement for the 2-amino group of purines. Proc Natl Acad Sci U S A (1967) 1.65
Prevalence of Shigella enterotoxins 1 and 2 among Shigella strains isolated from patients with traveler's diarrhea. J Clin Microbiol (1999) 1.63
Prospective study of manikin-only versus manikin and human subject endotracheal intubation training of paramedics. Ann Emerg Med (1991) 1.63
Clinical performance of a laser fluorescence device for detection of occlusal caries lesions. Eur J Oral Sci (2001) 1.62
Performance and reproducibility of a laser fluorescence system for detection of occlusal caries in vitro. Caries Res (1999) 1.62
Macrophage plasminogen activator: induction by asbestos is blocked by anti-inflammatory steroids. J Exp Med (1976) 1.60
Costs of resistance in insect-parasite and insect-parasitoid interactions. Parasitology (2002) 1.60
Specific protease deficiency in polymorphonuclear leukocytes of Chédiak-Higashi syndrome and beige mice. J Exp Med (1978) 1.60
Dietary patterns and associated lifestyles in preconception, pregnancy and postpartum. Eur J Clin Nutr (2006) 1.58
Purification of murine T cell growth factor. A lymphocyte mitogen with helper activity. J Exp Med (1981) 1.57
A specific labeling procedure for proteins on the outer surface of membranes. J Biol Chem (1972) 1.55
Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. JAMA (2001) 1.53
Increased resistance to quinolones in Campylobacter jejuni: a genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolates. Microbiol Immunol (1998) 1.53
Fibrinolysis associated with oncogenic transformation. Morphological correlates. J Biol Chem (1974) 1.50
Current status of treatment completion and fatality among tuberculosis patients in Spain. Int J Tuberc Lung Dis (2004) 1.50
Phospholipid composition of Rous sarcoma virus, host cell membranes and other enveloped RNA viruses. Virology (1971) 1.49
Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis. J Hepatol (1994) 1.49
Keratitis, ichthyosis, and deafness (KID) syndrome in half sibs. Pediatr Dermatol (1998) 1.49
Isolation and characterization of urokinase from human plasma. J Biol Chem (1982) 1.47
Ammonium ions as the source of nitrogen for tryptophan biosynthesis in whole cells of Escherichia coli. Biochim Biophys Acta (1967) 1.46
Dual phosphorylation and autophosphorylation in mitogen-activated protein (MAP) kinase activation. Biochem J (1993) 1.45
cDNA and gene nucleotide sequence of porcine plasminogen activator. Nucleic Acids Res (1984) 1.43
Plasminogen, the serum proenzyme activated by factors from cells transformed by oncogenic viruses. J Biol Chem (1974) 1.43
Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center. Antimicrob Agents Chemother (2011) 1.43
Antisense transcription: a critical look in both directions. Cell Mol Life Sci (2009) 1.42
Gene expression and cAMP. Proc Natl Acad Sci U S A (1985) 1.41
High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. Clin Microbiol Infect (2007) 1.40
Schinzel-Giedion syndrome: report of two sibs. Am J Med Genet (1995) 1.40
Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates. J Antimicrob Chemother (1999) 1.39
An improved assay for interleukin 2 (lymphocyte growth factor) produced by mitogen-activated lymphocytes. Aust J Exp Biol Med Sci (1980) 1.38
Etiology of traveller's diarrhea in Spanish travellers to developing countries. Eur J Epidemiol (1993) 1.38
Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation. Br J Haematol (1994) 1.38
Comparison of acquisition of resistant microorganisms and infections in critically-ill patients with and without malignancies. Minerva Anestesiol (2013) 1.38
[Incidence of enteropathogens in patients with human immunodeficiency virus infection]. Med Clin (Barc) (1994) 1.38
Acro-renal-ocular syndrome: expansion of the phenotype. Clin Dysmorphol (1998) 1.38
Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study. Clin Microbiol Infect (2005) 1.36
Spatial distribution of vital and dead microorganisms in dental biofilms. Arch Oral Biol (2001) 1.34
Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces. J Hosp Infect (2011) 1.33
Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance. J Urol (2007) 1.33
Decreased permeability and enhanced proton-dependent active efflux in the development of resistance to quinolones in Morganella morganii. Int J Antimicrob Agents (2000) 1.33
Experimental model for quantitative study of metastasis. Cancer Res (1980) 1.32
Exonuclease VI, a new nuclease activity associated with E. coli DNA polymerase. Proc Natl Acad Sci U S A (1968) 1.32
Changes in malignant phenotype of a human carcinoma conditioned by growth environment. Cell (1983) 1.31
RNA and protein synthesis in human peripheral blood polymorphonuclear leukocytes. J Exp Med (1979) 1.30
Selective lysis of cells transformed by Rous Sarcoma virus. Virology (1971) 1.29
Acetylcholine receptor. Responses to drug binding. J Biol Chem (1977) 1.29
SEPARATION OF THE BIOSYNTHESIS OF THE ANTIBIOTIC POLYPEPTIDE TYROCIDINE FROM PROTEIN BIOSYNTHESIS. Proc Natl Acad Sci U S A (1963) 1.28
Use of a three-day estimated food record, a 72-hour recall and a food-frequency questionnaire for dietary assessment in a Mediterranean Spanish population. Clin Nutr (2001) 1.28
CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii. Antimicrob Agents Chemother (2009) 1.27
Cholera outbreak in southern Tanzania: risk factors and patterns of transmission. Emerg Infect Dis (2001) 1.27
Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections. Clin Infect Dis (2001) 1.26
Fibrin overlay methods for the detection of single transformed cells and colonies of transformed cells. Cell (1975) 1.25
Etiology of first-ever ischaemic stroke in European young adults: the 15 cities young stroke study. Eur J Neurol (2013) 1.25
Liver transplantation in patients with portal vein thrombosis. Liver Transpl (2001) 1.23
Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother (2013) 1.21
Functional recovery after ischemic stroke--a matter of age: data from the Austrian Stroke Unit Registry. Neurology (2012) 1.21
Metabolism of acetylcholine receptor in chick embryo muscle cells: effects of RSV and PMA. Cell (1978) 1.20
Muscle differentiation in cell culture. Effects of nucleoside inhibitors and Rous sarcoma virus. J Biol Chem (1972) 1.19
Plasminogen activator in the bursa of Fabricius: correlations with morphogenetic remodeling and cell migrations. Cell (1981) 1.18
Correlation of six methods for typing nosocomial isolates of Acinetobacter baumannii. J Med Microbiol (1995) 1.17